266 related articles for article (PubMed ID: 27005662)
1. Perfringolysin O Theta Toxin as a Tool to Monitor the Distribution and Inhomogeneity of Cholesterol in Cellular Membranes.
Maekawa M; Yang Y; Fairn GD
Toxins (Basel); 2016 Mar; 8(3):. PubMed ID: 27005662
[TBL] [Abstract][Full Text] [Related]
2. Domain 4 (D4) of Perfringolysin O to Visualize Cholesterol in Cellular Membranes-The Update.
Maekawa M
Sensors (Basel); 2017 Mar; 17(3):. PubMed ID: 28273804
[TBL] [Abstract][Full Text] [Related]
3. Perfringolysin O: The Underrated Clostridium perfringens Toxin?
Verherstraeten S; Goossens E; Valgaeren B; Pardon B; Timbermont L; Haesebrouck F; Ducatelle R; Deprez P; Wade KR; Tweten R; Van Immerseel F
Toxins (Basel); 2015 May; 7(5):1702-21. PubMed ID: 26008232
[TBL] [Abstract][Full Text] [Related]
4. R468A mutation in perfringolysin O destabilizes toxin structure and induces membrane fusion.
Kulma M; Kacprzyk-Stokowiec A; Kwiatkowska K; Traczyk G; Sobota A; Dadlez M
Biochim Biophys Acta Biomembr; 2017 Jun; 1859(6):1075-1088. PubMed ID: 28263714
[TBL] [Abstract][Full Text] [Related]
5. Modifications in perfringolysin O domain 4 alter the cholesterol concentration threshold required for binding.
Johnson BB; Moe PC; Wang D; Rossi K; Trigatti BL; Heuck AP
Biochemistry; 2012 Apr; 51(16):3373-82. PubMed ID: 22482748
[TBL] [Abstract][Full Text] [Related]
6. Crucial role of perfringolysin O D1 domain in orchestrating structural transitions leading to membrane-perforating pores: a hydrogen-deuterium exchange study.
Kacprzyk-Stokowiec A; Kulma M; Traczyk G; Kwiatkowska K; Sobota A; Dadlez M
J Biol Chem; 2014 Oct; 289(41):28738-52. PubMed ID: 25164812
[TBL] [Abstract][Full Text] [Related]
7. Structural insights into the membrane-anchoring mechanism of a cholesterol-dependent cytolysin.
Ramachandran R; Heuck AP; Tweten RK; Johnson AE
Nat Struct Biol; 2002 Nov; 9(11):823-7. PubMed ID: 12368903
[TBL] [Abstract][Full Text] [Related]
8. Non-toxic perfringolysin O and α-toxin derivatives as potential vaccine candidates against bovine necrohaemorrhagic enteritis.
Verherstraeten S; Goossens E; Valgaeren B; Pardon B; Timbermont L; Haesebrouck F; Ducatelle R; Deprez P; Van Immerseel F
Vet J; 2016 Nov; 217():89-94. PubMed ID: 27810219
[TBL] [Abstract][Full Text] [Related]
9. Mechanistic Insights into the Cholesterol-dependent Binding of Perfringolysin O-based Probes and Cell Membranes.
Johnson BB; Breña M; Anguita J; Heuck AP
Sci Rep; 2017 Oct; 7(1):13793. PubMed ID: 29061991
[TBL] [Abstract][Full Text] [Related]
10. Oligomerization and hemolytic properties of the C-terminal domain of pyolysin, a cholesterol-dependent cytolysin.
Pokrajac L; Harris JR; Sarraf N; Palmer M
Biochem Cell Biol; 2013 Apr; 91(2):59-66. PubMed ID: 23527633
[TBL] [Abstract][Full Text] [Related]
11. Ostreolysin A and anthrolysin O use different mechanisms to control movement of cholesterol from the plasma membrane to the endoplasmic reticulum.
Johnson KA; Endapally S; Vazquez DC; Infante RE; Radhakrishnan A
J Biol Chem; 2019 Nov; 294(46):17289-17300. PubMed ID: 31597703
[TBL] [Abstract][Full Text] [Related]
12. High-resolution imaging and quantification of plasma membrane cholesterol by NanoSIMS.
He C; Hu X; Jung RS; Weston TA; Sandoval NP; Tontonoz P; Kilburn MR; Fong LG; Young SG; Jiang H
Proc Natl Acad Sci U S A; 2017 Feb; 114(8):2000-2005. PubMed ID: 28167768
[TBL] [Abstract][Full Text] [Related]
13. Phospholipid hydrolysis caused by Clostridium perfringens α-toxin facilitates the targeting of perfringolysin O to membrane bilayers.
Moe PC; Heuck AP
Biochemistry; 2010 Nov; 49(44):9498-507. PubMed ID: 20886855
[TBL] [Abstract][Full Text] [Related]
14. Contribution of individual tryptophan residues to the structure and activity of theta-toxin (perfringolysin O), a cholesterol-binding cytolysin.
Sekino-Suzuki N; Nakamura M; Mitsui KI; Ohno-Iwashita Y
Eur J Biochem; 1996 Nov; 241(3):941-7. PubMed ID: 8944786
[TBL] [Abstract][Full Text] [Related]
15. Cholesterol exposure at the membrane surface is necessary and sufficient to trigger perfringolysin O binding.
Flanagan JJ; Tweten RK; Johnson AE; Heuck AP
Biochemistry; 2009 May; 48(18):3977-87. PubMed ID: 19292457
[TBL] [Abstract][Full Text] [Related]
16. Identification of a membrane-spanning domain of the thiol-activated pore-forming toxin Clostridium perfringens perfringolysin O: an alpha-helical to beta-sheet transition identified by fluorescence spectroscopy.
Shepard LA; Heuck AP; Hamman BD; Rossjohn J; Parker MW; Ryan KR; Johnson AE; Tweten RK
Biochemistry; 1998 Oct; 37(41):14563-74. PubMed ID: 9772185
[TBL] [Abstract][Full Text] [Related]
17. How interaction of perfringolysin O with membranes is controlled by sterol structure, lipid structure, and physiological low pH: insights into the origin of perfringolysin O-lipid raft interaction.
Nelson LD; Johnson AE; London E
J Biol Chem; 2008 Feb; 283(8):4632-42. PubMed ID: 18089559
[TBL] [Abstract][Full Text] [Related]
18. Interaction of Cholesterol with Perfringolysin O: What Have We Learned from Functional Analysis?
Savinov SN; Heuck AP
Toxins (Basel); 2017 Nov; 9(12):. PubMed ID: 29168745
[TBL] [Abstract][Full Text] [Related]
19. Membrane disorganization induced by perfringolysin O (theta-toxin) of Clostridium perfringens--effect of toxin binding and self-assembly on liposomes.
Iwamoto M; Nakamura M; Mitsui K; Ando S; Ohno-Iwashita Y
Biochim Biophys Acta; 1993 Nov; 1153(1):89-96. PubMed ID: 8241254
[TBL] [Abstract][Full Text] [Related]
20. Detection of esterified cholesterol in murine Bruch's membrane wholemounts with a perfringolysin O-based cholesterol marker.
Rudolf M; Mohi A; Dettbarn MC; Miura Y; Aherrahrou Z; Ranjbar M; Mutus B; Knobloch JK
Invest Ophthalmol Vis Sci; 2014 Jul; 55(8):4759-67. PubMed ID: 24985479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
